Anzeige
Mehr »
Dienstag, 28.10.2025 - Börsentäglich über 12.000 News
Atomkraft feiert Comeback: Uran wird wieder zum strategischen Rohstoff - Anleger stehen Schlange
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche

Aktuelle News von Pharmaceutical Technology

  • 24 h
  • letzte 200 News
ZeitAktuelle Nachrichten
08.10.Oragenics partners Receptor.AI for brain health candidate portfolio
08.10.CDC amends Covid-19, chickenpox immunisation schedule amid vaccine controversy
08.10.Lilly's Omvoh benefit continues for four years in UC
06.10.Funds dry up for mRNA vaccines amid US political storm
06.10.FDA backs generics onshoring push with ANDA priority scheme
06.10.Rocket ditches blood disorder gene therapy in ongoing pipeline pivot
06.10.Trogenix lands $95m Series A, backed by Eli Lilly, for brain cancer therapy
06.10.Jazz and Roche's Zepzelca-Tecentriq wins FDA ES-SCLC approval
06.10.McMaster University and MIT discover new antibiotic for IBD
03.10.FDA approves mifepristone generic as political abortion war rages on
03.10.Takeda walks away from cell therapy in priority U-turn
03.10.Amgen's Phase III data supports FDA label expansion of Repatha
02.10.FDA winds down operations amid government shutdown
02.10.FDA leaders are "acting political", says ex-agency chief counsel
02.10.Halozyme eyes microparticles in $900m Elektrofi acquisition
02.10.AbbVie breaks ground on $70m US biologics site amid Trump pressure
01.10.US Government shuts down over funding impasse
01.10.Pfizer shakes hands with White House on drug discounts under MFN programme
01.10.Klotho to acquire Turn Biotechnologies' assets
01.10.Star Therapeutics gains $125m Series D funds to develop pipeline
01.10.Disruption due for long-held assumptions in biopharma, says BIA chair
30.09.Genmab to acquire Merus shares for $8bn
30.09.J&J gets FDA approval for Tremfya in paediatric psoriasis
30.09.NMPA approves Eisai and Biogen for Leqembi IV maintenance dosing
29.09.Amgen to invest $650m in US manufacturing network expansion